Browning West Files 13D/A on Gildan, Signaling Continued Activism
Ticker: GIL · Form: SC 13D/A · Filed: Jan 23, 2024 · CIK: 1061894
Complexity: simple
Sentiment: mixed
Topics: activist-investing, corporate-governance, shareholder-activism
TL;DR
**Activist investor Browning West is still pushing for changes at Gildan.**
AI Summary
Browning West LP, an activist investor, filed an Amendment No. 2 to its Schedule 13D on January 23, 2024, regarding its stake in Gildan Activewear Inc. This amendment indicates a continued active interest in Gildan, with the filing being triggered by an event on January 19, 2024. For investors, this signals ongoing pressure and potential changes at Gildan, which could impact the company's strategic direction and stock performance.
Why It Matters
This filing confirms that Browning West LP is maintaining its activist stance towards Gildan Activewear, suggesting potential future corporate actions or governance changes that could affect shareholder value.
Risk Assessment
Risk Level: medium — Activist investor involvement can lead to significant corporate changes, which carry both upside potential and execution risks for the company and its shareholders.
Analyst Insight
Investors should monitor future communications from Browning West LP and Gildan Activewear Inc. for any indications of strategic shifts or governance changes, as these could significantly impact the stock's valuation. This filing suggests continued activist pressure, which could lead to either positive or negative outcomes depending on the nature of the changes and their execution.
Key Players & Entities
- Browning West LP (company) — the activist investor filing the SC 13D/A
- Gildan Activewear Inc. (company) — the subject company of the SC 13D/A filing
- January 19, 2024 (date) — the date of the event requiring the filing
- Andrew M. Freedman (person) — contact person for notices and communications for Browning West LP
- Olshan Frome Wolosky LLP (company) — law firm representing Browning West LP
Forward-Looking Statements
- Browning West LP will continue to engage with Gildan Activewear Inc.'s management or board to advocate for its strategic objectives. (Gildan Activewear Inc.) — high confidence, target: Q2 2024
- Gildan Activewear Inc. may announce new corporate governance changes or strategic initiatives in response to activist pressure. (Gildan Activewear Inc.) — medium confidence, target: Q3 2024
FAQ
What type of SEC filing is this document?
This document is an Amendment No. 2 to a Schedule 13D, as indicated by 'FORM TYPE: SC 13D/A' and 'AMENDMENT NO. 2 TO THE SCHEDULE 13D'.
Who is the filer of this Schedule 13D/A?
The filer of this Schedule 13D/A is Browning West LP, as stated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BROWNING WEST LP'.
What is the subject company of this filing?
The subject company is Gildan Activewear Inc., as identified under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Gildan Activewear Inc.'.
What is the CUSIP number for Gildan Activewear Inc.'s Common Shares?
The CUSIP number for Gildan Activewear Inc.'s Common Shares is 375916103, as listed under 'CUSIP Number'.
When was the event that required the filing of this statement?
The date of the event which required the filing of this statement was January 19, 2024, as explicitly stated in the filing.
Filing Stats: 1,115 words · 4 min read · ~4 pages · Grade level 12.3 · Accepted 2024-01-23 17:15:22
Filing Documents
- sc13da212418013_01222024.htm (SC 13D/A) — 65KB
- ex991to13da212418013_012224.htm (EX-99.1) — 18KB
- 0000921895-24-000115.txt ( ) — 85KB
Purpose of Transaction
Item 4. Purpose of Transaction .
is hereby amended
Item 4 is hereby amended to add the following: The Reporting Persons are severely disappointed by the Issuer’s persistence in focusing on an irrelevant issue under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”). The Issuer’s seeming attempt to invalidate the Reporting Persons’ valid requisition for a Special Meeting of Shareholders is intended to distract from the substance of the matter at hand – namely, the Board’s extremely poor judgment in terminating Glenn Chamandy and hiring Vince Tyra to replace him, its refusal to engage in any kind of good faith reconsideration of that decision, and its subsequent conduct which is explicable only as being designed to entrench the Board, contrary to the best interests of the Issuer and its shareholders. Nevertheless, on January 19, 2024, Browning West Cayman Fund LP (“BW Cayman”) filed, expressly under protest, a Notification and Report Form with the Federal Trade Commission and the Antitrust Division of the U.S. Department of Justice. Such filing was made under protest on the grounds that certain acquisitions of Shares during December 2023 were not subject to the filing and waiting period requirements of the HSR Act because of the Reporting Persons’ good faith belief that BW Cayman is exempt from filing pursuant to 16 C.F.R. § 802.51(b). On January 21, 2024, the Reporting Persons issued a press release and open letter (the “January 21 Press Release”), in which the Reporting Persons emphasized their belief that the Board is now resorting to desperate and egregious entrenchment maneuvers to try and deprive its shareholders of the opportunity to replace the directors responsible for recent missteps and value destruction with the Reporting Persons’ highly qualified director candidates at the Special Meeting. In the January 21 Press Release, the Reporting Persons disclose that they were informed that the Bo
Material to be Filed as Exhibits
Item 7. Material to be Filed as Exhibits .
is hereby amended
Item 7 is hereby amended to add the following exhibit: 99.1 January 21 Press Release. 4 CUSIP No. 375916103
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: January 23, 2024 Browning West, LP By: /s/ Samuel Green Name: Samuel Green Title: Chief Compliance Officer and Chief Financial Officer /s/ Usman Nabi Usman Nabi 5